Scientists unveil synthetic cells to power low-carbon factories - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Scientists unveil synthetic cells to power low-carbon factories

Invention known as SpudCell is part of effort to use micro-scale bioengineering in manufacture of everyday items
00:00

{"text":[[{"start":7.7,"text":"Scientists have unveiled synthetic cells aimed at revolutionising industrial production by serving as tiny biological factories to make environmentally friendly materials for goods from drugs to plastics."}],[{"start":19.9,"text":"The new invention known as SpudCell will be made available to researchers around the world, as part of an expanding effort to put micro-scale bioengineering at the heart of lower-carbon manufacturing for everyday items.SpudCell is the first synthetic system to achieve a complete cell cycle of feeding, growth and reproduction, according to a paper released on Wednesday but not yet peer-reviewed. It is built from the bottom up using known non-living chemical components, as opposed to previous methods based on pared-down living cells and their naturally occurring parts."}],[{"start":54.4,"text":"The discovery highlights how progress in synthetic biology is opening dramatic new possibilities for turning cells from existing life forms and human-made variations on them into miniature workshops. The advances have intensified debate over how the powerful technologies should be owned and regulated, particularly if it one day becomes possible to make living organisms in laboratories.Bioengineered microbes are already used as miniature factories to make products such as insulin and biodegradable plastics. The consultancy McKinsey estimated in 2023 that 400 use cases of bioengineering more widely, almost all of them scientifically feasible, could have an annual economic impact of $2tn to $4tn from 2030 to 2040."}],[{"start":103.05,"text":"“We need to be able to manufacture things in a way that doesn’t harm the planet and in a way that’s actually renewable,” said Kate Adamala, leader of the SpudCell project and a University of Minnesota scientist. “We have enough atoms on this planet. We just need to move those atoms in a way that’s more sustainable — and also politically more decentralised.”"}],[{"start":122.55,"text":"“This is the first time the full cycle of a living cell has been run in a system that was built, not born — assembled from scratch rather than scaled down from something already alive,” the researchers said, noting that SpudCells could in principle be custom-built to make a variety of products. “This work opens up entire fields, and could ultimately underlie new therapeutics, materials, foods and approaches to carbon removal in the long-term future.”"}],[{"start":147.5,"text":"SpudCell still had several areas of scope for improvement, the scientists said. These include reducing its dependence on external food sources, increasing the sophistication of its reproduction mechanisms and building its own capacity to manufacture proteins."}],[{"start":162.45,"text":"The patent to SpudCell is owned by the University of Minnesota and exclusively licensed to Biotic, a US-based non-profit organisation with the stated aim of promoting the collaborative building of vital synthetic cell infrastructure. The researchers compare Biotic’s ambition to how the Human Genome Project was aimed at ensuring a “critical piece of human heritage” should “become a common scientific tool”."}],[{"start":187.64999999999998,"text":"The SpudCell work “opens the door to being able to have a simple system that can be asked to produce specific things at scale”, said Roseanna Zia, a University of Missouri engineering professor and expert on the modelling of biological cells.  "}],[{"start":202.89999999999998,"text":"Efforts by Biotic and other researchers could help ensure synthetic cell technology was not “locked up in patents that would allow only big companies to take advantage”, said John Glass, leader of the synthetic biology group at the J Craig Venter Institute."}],[{"start":218.74999999999997,"text":"“I think synthetic biology and synthetic cells can go a long way towards solving many of the world’s economic, medical, environmental and industrial problems,” Glass said. “Open-source or some version of open-source technology is the best way to make this happen.”"}],[{"start":235.84999999999997,"text":"Advances in bioengineering have stoked concerns about the potential for technologies to cause harm to living organisms, either through accidental leaks or deliberate targeting.  "}],[{"start":245.69999999999996,"text":"SpudCell cannot survive outside controlled laboratory conditions and so presents only a remote risk of use as a bioweapon, its creators argue."}],[{"start":255.24999999999997,"text":"Good governance of the development of synthetic cell technology was vital given the dangers posed by hackers and other bad actors, said Juan Pérez-Mercader, a senior research fellow at Harvard University’s Origins of Life Initiative."}],[{"start":268.79999999999995,"text":"“Guards must be placed lest we affect in irreversible ways the evolution of natural life,” Pérez-Mercader said. “Biotic could be a great first step in the direction of fostering the research and promoting necessary engineering standards and ethics.” "}],[{"start":291.29999999999995,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1783086940_7915.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

Z世代用TikTok拯救父母的时装店

Z世代用TikTok等社交媒体为父母经营的时装店吸引年轻顾客,帮助其走出困境。

加拿大企业担心特朗普关税引发“下行压力漩涡”

美加贸易战再起,与美国有业务往来的加拿大企业承受痛苦,面临不确定性。

FT社评:美财政部干预债券市场只是权宜之计

贝森特在日元和长期债券方面的举措,只能暂时缓解问题,无法解决政策可信度不足和债务过高的问题。

Lex专栏:希音首次公开募股推介应更多借鉴Meta而非H&M

它的竞争对手不只是服装零售商,还应包括任何为沉迷屏幕的用户带来多巴胺刺激的企业。

气候如何推动新的地缘战略?

环境变化正在重塑贸易、商业、物流和地缘政治。

“全民分担”的金融危机仍是危机

私募信贷与保险业的联姻热潮可能暗藏代价。
设置字号×
最小
较小
默认
较大
最大
分享×